The 411 on Superbugs: MRSA

Posted by Tru-D SmartUVC 05.24.16

TD149 viruses v2-page-001What is MRSA?

Methicillin-resistant Staphylococcus aureus (MRSA) infection is caused by a type of staph bacteria that’s become resistant to many of the antibiotics used to treat ordinary staph infections. MRSA can cause life-threatening bloodstream infections, pneumonia and surgical site infections, and it’s putting more patient lives at risk every single day.


How does MRSA spread?

Anyone can get MRSA through direct contact with an infected wound or by sharing personal items, such as towels or razors, that have touched infected skin. MRSA infection risk can be increased when a person is in certain activities or places that involve crowding, skin-to-skin contact, and shared equipment or supplies.

How is MRSA treated?

Hospitalized people with MRSA infections are usually treated with an intravenous medication. The intravenous antibiotic is usually continued until the person is improving. In many cases, the person will be given antibiotics after discharge from the hospital, either by mouth or by intravenous (IV).

Where does Tru-D come in?

In 2010, Tru-D was validated by three researchers from the University of North Carolina Health Care conducting a study on the effectiveness of a UVC–emitting device in eliminating nosocomial pathogens found in contaminated hospital rooms. By measuring the MRSA and Vancomycin-Resistant Enterococci (VRE) counts in patient rooms before and after patient occupation, researchers concluded that Tru-D was effective in eliminating these deadly pathogens. Specifically, the device destroyed vegetative bacteria on contaminated surfaces both in direct sight, as well as behind objects. Since this study, Tru-D has been validated by 10 additional studies, all concluding that Tru-D is effective in eliminating harmful pathogens.

“Tru-D allows hospitals to eliminate up to 99.9% of pathogens such as MRSA that can live in patient rooms and ORs,” said Chuck Dunn, president and CEO of Tru-D SmartUVC. “As more hospitals implement Tru-D into their terminal cleaning strategies, we will continue to see the incidence of these superbugs decrease.”

For more information and links to independent studies, click here.

Posted 05.24.16
  • Share

Never miss the latest in UV news.
Subscribe to UVC360 today.

Sign Up »